Package 66215-232-56

{"route": ["ORAL"], "spl_id": "f52a8c9c-529d-4bd8-9bfb-d91161935c20", "openfda": {"unii": ["Q326023R30"], "rxcui": ["349253", "352066", "656659", "656660", "1989081", "1989085"], "spl_set_id": ["749e42fb-2fe0-45dd-9268-b43bb3f4081c"], "manufacturer_name": ["Actelion Pharmaceuticals US, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 BLISTER PACK in 1 CARTON (66215-232-56)  / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK (66215-232-14)", "package_ndc": "66215-232-56", "marketing_start_date": "20210729"}], "brand_name": "Tracleer", "product_id": "66215-232_f52a8c9c-529d-4bd8-9bfb-d91161935c20", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Endothelin Receptor Antagonist [EPC]", "Endothelin Receptor Antagonists [MoA]"], "product_ndc": "66215-232", "generic_name": "bosentan", "labeler_name": "Actelion Pharmaceuticals US, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tracleer", "active_ingredients": [{"name": "BOSENTAN", "strength": "32 mg/1"}], "application_number": "NDA209279", "marketing_category": "NDA", "marketing_start_date": "20210729", "listing_expiration_date": "20271231"}